S748 Risankizumab Results in Improvements in Disease Activity Scores in Patients With Crohn's Disease: Post-Hoc Analysis of the Phase 3 Induction and Maintenance Studies. (October 2022) - Ferrante, Marc; Colombel, Jean-Frederic; Kligys, Kristina; Van Haaren, Stijn; Song, Alexandra; Neimark, Ezequiel; Zambrano, Javier; Liao, Xiaomei; Dubinsky, Marla